Cancer Genomics & Proteomics

Papers
(The TQCC of Cancer Genomics & Proteomics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells19
Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR6118
Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells18
Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts17
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and 17
Mesonephric-like Carcinosarcoma of the Uterine Corpus: Clinicopathological, Molecular and Prognostic Characteristics in Comparison With Uterine Mesonephric-like Adenocarcinoma and Conventional Endomet14
Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer13
Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes11
Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis11
Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells11
Whole-genome Sequencing Analysis of Bile Tract Cancer Reveals Mutation Characteristics and Potential Biomarkers10
Two DifferentNF1Pathogenic Variants in a Family With Neurofibromatosis Type 110
Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis10
Recurrent 8q11-13 Aberrations Leading toPLAG1Rearrangements, Including Novel ChimerasHNRNPA2B1::PLAG1andSDCBP::PLAG1, in Lipomatous Tumors9
Sex Hormone-regulatedCMG2Is Involved in Breast and Prostate Cancer Progression9
SH003 Causes ER Stress-mediated Apoptosis of Breast Cancer CellsviaIntracellular ROS Production8
Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape8
Targeting Autophagy With the Synergistic Combination of Chloroquine and Rapamycin as a Novel Effective Treatment for Well-differentiated Liposarcoma8
Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities7
Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A 7
NovelMYCBP::EHD2andRUNX1::ZNF780AFusion Genes in T-cell Acute Lymphoblastic Leukemia7
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer7
Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives6
Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer6
Machine-learning-based Analysis Identifies miRNA Expression Profile for Diagnosis and Prediction of Colorectal Cancer: A Preliminary Study6
In VivoEffects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model6
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells6
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome6
Circular RNAs With Efficacy in PreclinicalIn VitroandIn VivoModels of Esophageal Squamous Cell Carcinoma6
Mutational Signatures Associate With Survival in Gastrointestinal Carcinomas6
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia6
HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation5
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis5
Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by DifferentialVHLMutations Underlie Multifocal ccRCC5
Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study4
Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer Cells4
Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in PreclinicalIn VivoModels4
POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma4
Cytomorphology and Gene Expression Signatures of Anchorage-independent Aggregations of Oral Cancer Cells4
Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes4
Breast Cancer: Circular RNAs Mediating Efficacy in PreclinicalIn VivoModels4
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer4
Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells4
Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression4
Role of Genetic Variations inCDK2,CCNE1andp27KIP1in Prostate Cancer4
CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention3
Comparative Proteomics of ccRCC Cell Lines to Identify Kidney Cancer Progression Factors3
Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk3
Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma3
Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression3
Novel Contribution of Long Non-coding RNAMEG3Genotype to Prediction of Childhood Leukemia Risk3
Terrein Exhibits Anti-tumor Activity by Suppressing Angiogenin Expression in Malignant Melanoma Cells3
CEACAM6 Promotes Lung MetastasisviaEnhancing Proliferation, Migration and Suppressing Apoptosis of Prostate Cancer Cells3
Irradiated Cell-derived Exosomes Enhance Cell Proliferation and Radioresistanceviathe MAPK/Erk Pathway3
Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL)3
Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences3
Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma3
Engineering of an EPHA2-Targeted Monobody for the Detection of Colorectal Cancer3
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines3
Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden3
Impact of Prospero Homeobox-1 (PROX-1) οn the Oncogenic Phenotypes of Hepatocellular Carcinoma Cells3
Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines Three Distinct Subgroups of Renal Cell Carcinomas3
Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders3
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma C3
0.048686981201172